With the rapid evolution of medical technology and research, these guidelines are anticipated to reflect the latest evidence-based practices and provide valuable guidance to healthcare professionals in delivering optimal care to their patients. The forthcoming medical guidelines for 2025 hold immense potential to improve healthcare delivery and enhance patient outcomes.

Below are the top 10 most anticipated guidelines for the first half of 2025.

  1. ATS/IDSA – Community-Acquired Pneumonia Update
    • Updates a very popular guideline from 2019.
  1.  ATS – Treatment of Pediatric Pulmonary Hypertensions
    • A stand-alone guideline from ATS on this topic, updating the previous guidance from 2015 which was co-developed with AHA.
  1. ACC/AHA – Acute Coronary Syndromes
    • A major new update from ACC/AHA expected in the first half of the year.
  1. AAO-HNS – Surgical Management of Chronic Sinusitis
    • Long-awaited and anticipated, this new guideline should finally publish in the first half of 2025.
  1. IDSA – Complicated Intra-Abdominal Infections (Part II)
    • A follow up to the Pt I diagnostic guideline released in late 2024, the part II guidance is focused on medical management of cIAI.
  1. ASCO – Treatment of Multiple Myeloma
    • Previously released for a public comment period a few months ago, this is the first update to ASCO’s multiple myeloma guideline since 2019.
  1. ACC/AHA – High Blood Pressure
    • A focused update, similar to the HCM guidelines in 2024, it is among the most highly anticipated publications in 2025.
  1. ATA – Differentiated Thyroid Cancer – DTC
    • After years of hard work, the ATA is finally nearing the release of their popular differentiated thyroid cancer guidelines, last updated in 2015. This will be split into multiple parts, with the DTC portion planning in the first half of the year, while the thyroid nodules portion should follow later on.
  1. GINA – Asthma (2025)
    • The very popular yearly update to GINA’s asthma guidelines are expected in the first part of this year.
  1. ES – Primary Aldosteronism
    • This will be the first primary aldosteronism guideline update from the Endocrine Society since 2016.

Thank you for taking the time to read this article. We value your feedback, so please do not hesitate to share any future guidelines that you are looking forward to in the upcoming year. Don't forget to sign up for alerts to stay informed on the latest published guidelines. Stay tuned for our upcoming conference previews and recaps.

Copyright © 2025 Guideline Central, All Rights Reserved.